Central line maintenance bundles and clabsis in ambulatory oncology patients

Pediatrics

Volumn 132, Issue 5, 2013, Pages

  Rinke, Michael L ^a   Bundy, David G ^b   Chen, R ^c   Milstone, Aaron M ^d,e   Colantuoni, Elizabeth ^f   Pehar, Miriana ^e   Herpst, Cynthia ^g   Fratino, Lisa ^g   Miller, Marlene R ^c,h  

^a CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Departments of Hospital Epidemiology and Infection Control   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g JOHNS HOPKINS HOSPITAL   (United States)

^h Children's Hospital Association   (United States)

Author keywords

Central line associated bloodstream infection; Central venous catheter access device; Epidemiology; Oncology; Outpatient management; Pediatric; Quality improvement

Indexed keywords

ADOLESCENT; ADULT; AMBULATORY CARE; ARTICLE; BACTEREMIA; CANCER PATIENT; CATHETER COMPLICATION; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; FAMILY; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MORBIDITY; MUCOSA INFLAMMATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STAFF NURSE; STAFF TRAINING; CANCER CENTER; CARE BUNDLE; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERIZATION; COHORT ANALYSIS; MICROBIOLOGY; PROCEDURES; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STANDARDS; YOUNG ADULT;

ADOLESCENT; AMBULATORY CARE; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CENTRAL VENOUS CATHETERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; MALE; ONCOLOGY SERVICE, HOSPITAL; PATIENT CARE BUNDLES; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84887088044     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-0302     Document Type: Article

References (36)

1. Pulte D, Gondos A, Brenner H. Trends in 5- And 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004. J Natl Cancer Inst. 2008;100(18):1301- 1309.
2. Pulte D, Gondos A, Brenner H. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005. Cancer. 2009;115(21):4973- 4979.
3. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health careassociated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5): 309-332. (Pubitemid 351763841)
4. Dudeck MA, Horan TC, Peterson KD, et al. National Healthcare Safety Network (NHSN) report, data summary for 2010, deviceassociated module. Am J Infect Control. 2011;39(10):798-816.
5. Schulman J, Stricof R, Stevens TP, et al; New York State Regional Perinatal Care Centers. Statewide NICU centralline- Associated bloodstream infection rates decline after bundles and checklists. Pediatrics. 2011;127(3):436- 444.
6. Castello FV, Maher A, Cable G. Reducing bloodstream infections in pediatric rehabilitation patients receiving parenteral nutrition. Pediatrics. 2011;128(5). Available at: www.pediatrics.org/cgi/content/full/128/5/e1273.
7. Barrell C, Covington L, Bhatia M, et al. Preventive strategies for central lineassociated bloodstream infections in pediatric hematopoietic stem cell transplant recipients. Am J Infect Control. 2012;40(5): 434-439.
8. Miller MR, Griswold M, Harris JM II, et al. Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics. 2010;125(2): 206-213.
9. Miller MR, Niedner MF, Huskins WC, et al; National Association of Children's Hospitals and Related Institutions Pediatric Intensive Care Unit Central Line-Associated Bloodstream Infection Quality Transformation Teams. Reducing PICU central lineassociated bloodstream infections: 3-year results. Pediatrics. 2011;128(5). Available at: www.pediatrics.org/cgi/content/full/128/ 5/e1077.
10. Rinke ML, Chen AR, Bundy DG, et al. Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patients. Pediatrics. 2012;130(4). Available at: www.pediatrics.org/cgi/content/full/130/4/e996.
11. Choi SW, Chang L, Hanauer DA, et al. Rapid reduction of central line infections in hospitalized pediatric oncology patients through simple quality improvement methods. Pediatr Blood Cancer. 2013;60(2): 262-269.
12. Wheeler DS, Giaccone MJ, Hutchinson N, et al. A hospital-wide quality-improvement collaborative to reduce catheterassociated bloodstream infections. Pediatrics. 2011;128(4). Available at: www. pediatrics.org/cgi/ content/full/128/4/e995; quiz: E1004.
13. Smith TL, Pullen GT, Crouse V, Rosenberg J, Jarvis WR. Bloodstream infections in pediatric oncology outpatients: A new healthcare systems challenge. Infect Control Hosp Epidemiol. 2002;23(5):239- 243. (Pubitemid 34525265)
14. Abbas AA, Fryer CJ, Paltiel C, et al. Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study. Pediatr Blood Cancer. 2004;42(4): 325-331. (Pubitemid 38327625)
15. Adler A, Yaniv I, Solter E, et al. Catheterassociated bloodstream infections in pediatric hematology-oncology patients: factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol. 2006;28 (1):23-28. (Pubitemid 43361614)
16. Adler A, Yaniv I, Steinberg R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematologyoncology patients. J Hosp Infect. 2006;62(3): 358-365. (Pubitemid 43192330)
17. Allen RC, Holdsworth MT, Johnson CA, et al. Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer. 2008;51(1):53-58. (Pubitemid 351720869)
18. Kallen AJ, Patel PR, O'Grady NP. Preventing catheter-related bloodstream infections outside the intensive care unit: Expanding prevention to new settings. Clin Infect Dis. 2010;51(3):335-341.
19. Shah SS, Manning ML, Leahy E, Magnusson M, Rheingold SR, Bell LM. Central venous catheter-associated bloodstream infections in pediatric oncology home care. Infect Control Hosp Epidemiol. 2002;23(2): 99-101. (Pubitemid 34205643)
20. Rinke ML, Milstone AM, Chen AR, et al. Ambulatory pediatric oncology CLABSIs: Epidemiology and risk factors [published online ahead of print July 23, 2013]. Pediatric Blood and Cancer. doi:10.1002/pbc.24677.
21. Munro FD, Gillett PM, Wratten JC, et al. Totally implantable central venous access devices for paediatric oncology patients. Med Pediatr Oncol. 1999;33(4): 377-381. (Pubitemid 29449348)
22. Downes KJ, Metlay JP, Bell LM, McGowan KL, Elliott MR, Shah SS. Polymicrobial bloodstream infections among children and adolescents with central venous catheters evaluated in ambulatory care. Clin Infect Dis. 2008;46(3):387- 394. (Pubitemid 351263522)
23. Centers for Disease Control and Prevention. Central line-associated bloodstream infection (CLABSI) event. Published 2011. Available at: www.cdc.gov/nhsn/pdfs/pscmanual/4psc-clabscurrent.pdf Accessed January 18, 2012.
24. O'Grady NP, Alexander M, Burns LA, et al; Healthcare Infection Control Practices Advisory Committee. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011;39(4 suppl 1):S1- S34.
25. Nolan T, Berwick DM. All-or-none measurement raises the bar on performance. JAMA. 2006;295(10):1168-1170. (Pubitemid 43352347)
26. Ramsay CR, Matowe L, Grilli R, Grimshaw JM, Thomas RE. Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies. Int J Technol Assess Health Care. 2003;19(4): 613-623. (Pubitemid 38405635)
27. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica. 1980;48(4):817-830.
28. Huber PJ. The Behavior of Maximum Likelihood Estimates Under Nonstandard Conditions. Berkeley, CA: University of California Press; 1967.
29. Nelson LS. Technical aids. J Qual Technol. 1984;16(4):237-239.
30. Davis RE, Jacklin R, Sevdalis N, Vincent CA. Patient involvement in patient safety: what factors influence patient participation and engagement? Health Expect. 2007;10(3): 259-267. (Pubitemid 47196355)
31. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: Excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271 (20):1598-1601.
32. Centers for Disease Control and Prevention. Vital signs: central lineassociated blood stream infections- United States, 2001, 2008, and 2009. MMWR Morb Mortal kly Rep. 2011;60(8): 243-248.
33. Milstone AM, Elward A, Song X, et al; Pediatric SCRUB Trial Study Group. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: A multicentre, cluster-randomised, crossover trial. Lancet. 2013;381(9872):1099- 1106.
34. Lee GM, Kleinman K, Soumerai SB, et al. Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med. 2012;367(15):1428-1437.
35. Ketelaar NA, Faber MJ, Flottorp S, Rygh LH, Deane KH, Eccles MP. Public release of performance data in changing the behaviour of healthcare consumers, professionals or organisations. Cochrane Database Syst Rev. 2011;(11): CD004538.
36. Miller MR, Bundy DG. Quality transformation efforts: no quick fixes. Pediatrics. 2011;127(3):571-572.